Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (40)

2024

  1. Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study

    Clinical and Translational Oncology

  2. Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study

    Clinical and Translational Oncology

2023

  1. Substance P and Neurokinin-1 Receptor System in Thyroid Cancer: Potential Targets for New Molecular Therapies

    Journal of Clinical Medicine, Vol. 12, Núm. 19

2022

  1. Substance p and neurokinin 1 receptor in chronic inflammation and cancer of the head and neck: A review of the literature

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 1

  2. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

    European Journal of Surgical Oncology, Vol. 48, Núm. 5, pp. 1123-1132

2021

  1. Significance of the overexpression of substance p and its receptor nk-1r in head and neck carcinogenesis: A systematic review and meta-analysis

    Cancers, Vol. 13, Núm. 6, pp. 1-16

2020

  1. Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM

    Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 647-662

  2. Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)

    European Journal of Cancer Care, Vol. 29, Núm. 4

2019

  1. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 55-63

2017

  1. Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction

    Histology and Histopathology, Vol. 32, Núm. 6, pp. 627-637

  2. Sellar collision tumor involving a primary fibrosarcoma: Clinical, morphological and immunohistochemical study of a case and review of the literature

    Endocrinologia, Diabetes y Nutricion, Vol. 64, Núm. 3, pp. 176-178

2015

  1. Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: The phase II AVAXIRI study

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Clinical and Translational Oncology, Vol. 16, Núm. 3, pp. 243-256

2013

  1. E-cadherin in non-tumor epithelium adjacent to oral cancer as risk marker for the development of multiple tumors

    British Journal of Oral and Maxillofacial Surgery, Vol. 51, Núm. 2, pp. 157-163

  2. Recomendaciones para la Determinación de Biomarcadores en Tumores Endocrinos Gastroenteropancreáticos. Consenso nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica

    Revista Espanola de Patologia

2012

  1. A descriptive epidemiologic study of cleft lip and palate in Spain

    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 114, Núm. SUPPL. 5

  2. Clinical significance of langerhans cells in squamous cell carcinoma of the larynx

    Journal of Oncology

2011

  1. Calpain 10 gene and laryngeal cancer: A survival analysis

    Head and Neck, Vol. 33, Núm. 1, pp. 72-76

2010

  1. Analysis of Ki-67 expression in oral squamous cell carcinoma: Why Ki-67 is not a prognostic indicator

    Oral Oncology, Vol. 46, Núm. 7, pp. 525-530

  2. Ki-67 expression in non-tumour epithelium adjacent to oral cancer as risk marker for multiple oral tumours

    Oral Diseases, Vol. 16, Núm. 1, pp. 68-75